Todd Wider, M.D.

Todd Wider, M.D.

DirectoratASP Isotopes· In proxies 2023–2024

Todd Wider, M.D. sits on 12 public boards.

Boards1

  • ASP IsotopesDirector · 3 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. ASP IsotopesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +19%
  2. Varian BiopharmaPublic company
    • Director? – PresentNo stock prices for these years
  3. Xanadu BioPublic company
    • Director? – PresentNo stock prices for these years
  4. ARYA IIIPublic company
    • Director? – PresentNo stock prices for these years
  5. ARYA Sciences Acquisition Corp IPublic company
    • Director? – PresentNo stock prices for these years
  6. ARYA Sciences Acquisition Corp IIPublic company
    • Director? – PresentNo stock prices for these years
  7. ARYA Sciences Acquisition Corp IVPublic company
    • Director? – PresentNo stock prices for these years
  8. ARYE)Public company
    • Director? – PresentNo stock prices for these years
  9. Abeona Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Cerevel TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  11. LyfebulbPublic company
    • Director? – PresentNo stock prices for these years
  12. Nautilus BiotechnologyPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?